Senior Vice President, Sales, Service & Business Development
At Abcam, I lead the global Sales, Service and Business Development teams. Our focus is to connect, support and collaborate with customers and partners to help deliver scientific breakthroughs. I am very excited to work with a passionate, multi-national, multi-lingual team who are serving the life sciences community in over 130 countries to select the right products and services relevant to their research. Helping accelerate R&D outcomes that ultimately have a positive impact on society.
The business of science and supporting researchers to do great science has always been my passion and so I was delighted to join the team. Prior to joining Abcam I was Chief Executive of Isogenica, a contract research organisation specialising in single domain therapeutic antibody discovery. Before that I was CEO of Organ-on-Chip pioneer CN Bio Innovations, building and selling lab equipment and services for in vitro alternatives to animal studies.
I am a chemist by training with degrees from the University of Bristol, Massachusetts Institute of Technology and the University of Oxford (DPhil). I am involved in a number of organizations and networks that promote women in business, science and technology.
At the end of her first week at Abcam, Emma shares her thoughts about the evolution of the biotech sector, the effect of COVID-19 on the industry, and her views about Abcam’s position in this ever-changing landscape.